✦ LIBER ✦

T1047 Efficacy and Safety of Ultrase Mt20® (UMT20) in Improving the Coefficient of Fat Absorption in Children with Cystic Fibrosis and Pancreatic Insufficiency

✍ Scribed by Konstan, Michael W.; Strausbaugh, Steven; Nasr, Samya Z.; Graff, Gavin R.; Spénard, Jean; Grondin, Josée

Book ID: 122978360
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 68 KB
Volume: 136
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(09)62247-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ultrase MT12 and Ultrase MT20 in the tre

Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy

✍ M. W. Konstan; R. C. Stern; J. R. Trout; J. M. Sherman; H. Eigen; J. S. Wagener; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

S1333 Efficacy and Safety of Ultrase® MT

S1333 Efficacy and Safety of Ultrase® MT20 in Treating Pancreatic Insufficiency in Cystic Fibrosis

✍ KONSTAN, M; LIOU, T; STRAUSBAUGH, S; AHRENS, R; KANGA, J; GRAFF, G; MOFFETT, K; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Efficacy and safety of Creon® 24,000 in

Efficacy and safety of Creon® 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis

✍ Bruce C. Trapnell; Karen Maguiness; Gavin R. Graff; David Boyd; Katrin Beckmann; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 422 KB

S2059 Efficacy and Safety of Pancrelipas

S2059 Efficacy and Safety of Pancrelipase Delayed-Release Capsules in Patients with Pancreatic Insufficiency Due to Cystic Fibrosis

✍ Trapnell, Bruce; Maguiness, Karen M.; Graff, Gavin R.; Boyd, David; Caras, Steve 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A comparison of the efficacy and toleran

A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency

✍ Robert C Stern; Jay D Eisenberg; Jeff S Wagener; Richard Ahrens; Michael Rock; G 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 61 KB

Safety and Tolerability of a New Formula

Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis

✍ , Prof. Gavin R. Graff Professor and Chief Pediatric Pulmonology, John McNamara, 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 179 KB